Analysis of Erythrocyte Glycophorin-A Variants by Flow Cytometry in Lung Disease Patients Detects the Effect of Tobacco Smoke

The glycophoryn A (GPA) assay evaluates somatic in vivo mutations. It is considered a cumulative biodosimeter for genotoxic exposures and is under evaluation in cancer risk assessment.

Bibliographic Details
Published in:Analytical Cellular Pathology
Main Authors: Monica Neri, Elio Geido, Rosangela Filiberti, Roberto Orecchia, Angela Di Vinci, Mara Cafferata, Elisabetta Tassara, Riccardo Puntoni, Walter Giaretti
Format: Article
Language:English
Published: Wiley 2000-01-01
Online Access:http://dx.doi.org/10.1155/2000/512786
Description
Summary:The glycophoryn A (GPA) assay evaluates somatic in vivo mutations. It is considered a cumulative biodosimeter for genotoxic exposures and is under evaluation in cancer risk assessment.
ISSN:0921-8912
1878-3651